Sanara MedTech (SMTI) EBIAT (2016 - 2025)
Sanara MedTech (SMTI) has disclosed EBIAT for 15 consecutive years, with $834493.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, EBIAT fell 84.15% year-over-year to $834493.0, compared with a TTM value of -$14.6 million through Sep 2025, down 7635.02%, and an annual FY2024 reading of -$9.9 million, down 130.34% over the prior year.
- EBIAT was $834493.0 for Q3 2025 at Sanara MedTech, up from -$2.0 million in the prior quarter.
- Across five years, EBIAT topped out at $5.3 million in Q3 2024 and bottomed at -$9.9 million in Q4 2024.
- Average EBIAT over 5 years is -$1.8 million, with a median of -$1.8 million recorded in 2024.
- Peak annual rise in EBIAT hit 549.3% in 2024, while the deepest fall reached 7780.35% in 2024.
- Year by year, EBIAT stood at -$3.6 million in 2021, then dropped by 17.06% to -$4.2 million in 2022, then skyrocketed by 96.98% to -$125739.0 in 2023, then tumbled by 7780.35% to -$9.9 million in 2024, then skyrocketed by 108.42% to $834493.0 in 2025.
- Business Quant data shows EBIAT for SMTI at $834493.0 in Q3 2025, -$2.0 million in Q2 2025, and -$3.5 million in Q1 2025.